These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32285318)

  • 1. Random forest for prediction of contrast-induced nephropathy following coronary angiography.
    Liu Y; Chen S; Ye J; Xian Y; Wang X; Xuan J; Tan N; Li Q; Chen J; Ni Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):983-991. PubMed ID: 32285318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention.
    Gurm HS; Seth M; Kooiman J; Share D
    J Am Coll Cardiol; 2013 Jun; 61(22):2242-8. PubMed ID: 23721921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
    Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography.
    Liu L; Liu J; Lei L; Wang B; Sun G; Guo Z; He Y; Song F; Lun Z; Liu B; Chen G; Chen S; Yang Y; Liu Y; Chen J
    BMC Cardiovasc Disord; 2020 Aug; 20(1):399. PubMed ID: 32867690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.
    Yin WJ; Yi YH; Guan XF; Zhou LY; Wang JL; Li DY; Zuo XC
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
    Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
    Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
    Ji L; Su X; Qin W; Mi X; Liu F; Tang X; Li Z; Yang L
    Nephrology (Carlton); 2015 Aug; 20(8):544-51. PubMed ID: 25706048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Cardiovascular Data Registry-Acute Kidney Injury (NCDR) vs. Mehran risk models for prediction of contrast-induced nephropathy and need for dialysis after coronary angiography in a German patient cohort.
    Parco C; Brockmeyer M; Kosejian L; Quade J; Tröstler J; Bader S; Lin Y; Sokolowski A; Hoss A; Heinen Y; Schulze V; Icks A; Jung C; Kelm M; Wolff G
    J Nephrol; 2021 Oct; 34(5):1491-1500. PubMed ID: 34363595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
    Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
    Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model.
    Nusca A; Mangiacapra F; Sticchi A; Polizzi G; D'Acunto G; Ricottini E; Melfi R; Gallo P; Miglionico M; Giannone S; Ussia GP; Grigioni F
    Am J Cardiol; 2021 Sep; 155():16-22. PubMed ID: 34284868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
    Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular end diastolic pressure and contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Lima FV; Singh S; Parikh PB; Gruberg L
    Cardiovasc Revasc Med; 2018 Sep; 19(6S):16-20. PubMed ID: 29929842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.